'Unfounded Concerns': Hyperliquid Slams CME and ICE Regulatory Push

TL;DR

Hyperliquid has rebutted claims from CME and ICE that it lacks regulatory compliance, calling the concerns unfounded. The DeFi platform is expanding into traditional finance while emphasizing the advantages of on-chain technology.

Key points

Hyperliquid responds to CME and ICE's regulatory push
Claims of lacking KYC/AML controls are called unfounded
Hyperliquid emphasizes advantages of on-chain technology
The platform is expanding into traditional finance
Willingness to cooperate with U.S. regulators

Mentioned in this story

HyperliquidCMEICE

The decentralized platform Hyperliquid publicly responded to a Bloomberg report claiming that major traditional exchanges - CME and ICE, the parent company of NYSE - had urged U.S. regulators to intervene in the platform's operations. The conflict between legacy exchanges and the DeFi platform intensified as Hyperliquid stopped operating as a purely crypto-native venue and began directly expanding into TradFi territory.

The traditional financial sector is increasingly concerned about the rapid expansion of the on-chain 24/7 derivatives market, accusing Hyperliquid of lacking KYC/AML controls and enabling potential price manipulation.

Hyperliquid representatives called these claims "unfounded concerns", arguing that public blockchains, on the contrary, eliminate hidden manipulation. In its statement, the DeFi exchange emphasized the technological superiority of the on-chain model over traditional centralized exchanges, including:

Hostile environment for insiders
Assistance for regulators
24/7 efficiency
Elimination of price gaps

The platform acknowledged that current U.S. legislation is not designed for public blockchains and expressed willingness to cooperate with Washington to integrate into the legal framework.

Today, Bloomberg reported on certain incumbent traditional exchanges raising concerns about the integrity and impact of markets for perpetual derivatives on Hyperliquid.

These concerns are unfounded.

Hyperliquid offers enhanced market transparency, publishing a complete onchain…

— Hyperliquid Policy Center (@HyperliquidPC) May 15, 2026

Why CME and ICE fear Hyperliquid

The reaction from CME and ICE coincided with Hyperliquid's emergence as a systemic player whose infrastructure is beginning to compete directly with the U.S. stock market. As an example, ahead of AI chipmaker Cerebras' Nasdaq debut, daily trading volume for pre-IPO contracts on Hyperliquid exceeded $230 million, while the official Nasdaq premarket generated only around $30 million.

Q&A

What are Hyperliquid's main arguments against CME and ICE's regulatory concerns?

Hyperliquid argues that public blockchains eliminate hidden manipulation and provide technological advantages over traditional exchanges.

How is Hyperliquid expanding into traditional finance?

Hyperliquid is transitioning from a purely crypto-native platform to directly engaging with traditional finance markets.

What issues do CME and ICE have with Hyperliquid's operations?

CME and ICE are concerned about Hyperliquid's lack of KYC/AML controls and the potential for price manipulation in the on-chain derivatives market.